CoraLite®594-conjugated ACKR2 Monoclonal antibody

ACKR2 Monoclonal Antibody for IF-P
Cat No. CL594-60046
Clone No.1A3A2

Host / Isotype

Mouse / IgG1

Reactivity

human

Applications

IF-P

ACKR2, C C chemokine receptor D6, CCBP2, CCR10, CCR9, chemokine binding protein 2, Chemokine binding protein D6, Chemokine receptor CCR 10, Chemokine receptor CCR 9, CMKBR9, D6, hD6

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  CoraLite®594
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive IF-P detected inhuman tonsillitis tissue

Recommended dilution

ApplicationDilution
Immunofluorescence (IF)-PIF-P : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

CL594-60046 targets ACKR2 in IF-P applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen ACKR2 fusion protein Ag1941 Predict reactive species
Full Name chemokine binding protein 2
Calculated Molecular Weight 43 kDa
GenBank Accession NumberBC008816
Gene Symbol ACKR2
Gene ID (NCBI) 1238
RRIDAB_2919889
Conjugate CoraLite®594 Fluorescent Dye
Excitation/Emission Maxima Wavelengths588 nm / 604 nm
Form Liquid
Purification MethodProtein G purification
UNIPROT IDO00590
Storage Buffer PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
Storage ConditionsStore at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

ACKR2, also named as CCBP2 or chemokine receptor D6, is a heptahelical membrane protein expressed by lymphatic endothelial cells, binding with high affinity to multiple proinflammatory CC chemokines.

Protocols

Product Specific Protocols
IF protocol for CL594 ACKR2 antibody CL594-60046Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...